| 2790 Tobacco Use: Influence on 72 Month Survival of Ankylos Implants | ||
|
H. MORRIS1, S. OCHI2, P.M. LAMBERT3, and P.M. CRUM2, 1Department of Veteran's Affairs, Ann Arbor, MI, USA, 2VA Medical Center, Ann Arbor, MI, USA, 3VA Medical Center, Dayton, OH, USA OBJECTIVE: Clinical assessment of the influence of tobacco use on survival of a new and innovative implant design (ANKYLOS). METHODS: A total of 578 patients (786 cases) were screened using well defined inclusion criteria -- 550 patients patients were determined to be eligible and implants were placed in 465 patients -- follow up data was gathered up to 72 months. RESULTS: 43.5% of the females and 67.5% of the males acknowledged the use of tobacco (p=0.002 Chi-square). There was a trend suggesting lower proportion of younger patients used tobacco (p=0.01). The highest proportion of non-tobacco patients was in healthy ASA group (55.5%) and 91.7% in severe ASA group (p=0.001). Mean no. years of tobacco use = 33.5. Survival ranged from 96.7% for non-tobacco users and 95.9% for tobacco users (p=0.472). DISCUSSION: In this study, implant survival was not influenced by the patients use of tobacco. CONCLUSION: The survival of this implant, over a period of 72 months, was not affected by the patients use of tobacco. Supported by: Deparment of Veterans Affairs and Degussa-Dental (now Dentsply-Friadent-GmbH, Mannheim, Germany) | ||
| Seq #287 - Keynote Address and Implant Prosthodontics 12:30 PM-2:30 PM, Friday, 12 March 2004 Hawaii Convention Center 321-B | ||
|
Back to the Prosthodontics Research Program
| ||